Solid forms of (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9h-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use

-9. (canceled)

A crystal form comprising a citrate salt of Compound 1, or a tautomer thereof:

• which has an X-ray powder diffraction pattern comprising peaks at 4.8, 9.6, 18.9, and 19.2° 2θ (±0.2° 2θ).

-12. (canceled)

A crystal form comprising a hydrochloride salt of Compound 1, or a tautomer thereof:

• which has an X-ray powder diffraction pattern comprising peaks at 9.0, 9.8, 9.9, and 16.7° 2θ (±0.2° 2θ).

-20. (canceled)

(canceled)

(canceled)

-45. (canceled)

(canceled)

-52. (canceled)

(canceled)

(canceled)

-62. (canceled)